Market Leadership StudyKIK is a recognized leader in patient recruitment and retention technology within the clinical research industry, serving a broad client base including CROs, sponsors, and research sites. Its extensive reach with over 6 million patients connected demonstrates significant market influence and potential for expansion into new therapeutic areas.

Innovative Technologies The company leverages advanced digital tools such as mobile apps, telemedicine, eConsent, and social media advertising, positioning it as a cutting-edge provider capable of integrating into modern, technology-driven clinical trials, which can be a strong selling point for organizations seeking innovative solutions.

Recent Industry Recognition Winning the Participation Engagement Award for its Oncology Study App highlights StudyKIK’s innovative approach to patient communication and engagement, opening doors for sales opportunities in specialized and difficult-to-recruit therapeutic areas seeking similar cutting-edge engagement solutions.

Growth through Acquisition Since its acquisition by Syneos Health in September 2021, StudyKIK benefits from increased resources and industry credibility, offering a compelling value proposition for clients seeking integrated, technology-enabled recruitment and retention services backed by a global healthcare leader.

Financial Potential With an estimated revenue between $25 million and $50 million and a dedicated team of up to 200 employees, StudyKIK has established a stable financial position, making it a reliable partner for expanding clinical trial recruitment efforts across multiple therapeutic areas and geographical regions.